APA (7th ed.) Citation

Laguna, A., Martínez-Alonso, B., Guarnizo-Herrero, V., Nué-Martinez, J. J., Dardonville, C., Torrado-Santiago, S., & Torrado-Salmerón, C. (2025). Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. MDPI AG.

Chicago Style (17th ed.) Citation

Laguna, Almudena, Borja Martínez-Alonso, Víctor Guarnizo-Herrero, J. Jonathan Nué-Martinez, Christophe Dardonville, Santiago Torrado-Santiago, and Carlos Torrado-Salmerón. Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. MDPI AG, 2025.

MLA (9th ed.) Citation

Laguna, Almudena, et al. Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. MDPI AG, 2025.